GVR Report cover Veterinary Artificial Insemination Market Size, Share & Trends Report

Veterinary Artificial Insemination Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Swine, Ovine & Caprine, Equine), By Product (Normal Semen, Sexed Semen), By End-user, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-3-68038-570-0
  • Number of Pages: 140
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Report Overview

The global veterinary artificial insemination market size was valued at USD 4.2 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030. Growing demand for improved animal efficiency and productivity, demand for animal protein, supportive initiatives by industry stakeholders, need for sustainable food production, and adoption of sexed semen in developing markets are some of the key drivers of this market. Genus IntelliGenTM is Genus’ sexed semen technology that is used to develop sexed bovine genetics for Red Sindhi, Gir, Jersey, Holstein, Sahiwal Crossbreeds, and Mehsana and Murrah buffaloes, under the ‘Sexcel’ brand in India.

North America veterinary artificial insemination market size, by animal type, 2020 - 2030 (USD Billion)

The COVID-19 pandemic presented several challenges for the market for veterinary artificial insemination. This included challenges in performing AI procedures on-site, dampened demand for AI products and services, and risks and uncertainty due to fluctuating consumption patterns across several key markets. However, the pandemic along with other disease break-outs during the period such as the African Swine Fever (ASF), highlighted the need to produce superior livestock to secure the food source. To safeguard employees and farmers against Covid-19, in June 2020, the Animal Husbandry Department of India launched a program. Under this program, the department was offering telephonic assistance to animal farm owners. In addition, artificial insemination services were being delivered to farmers at their doorstep during the lockdown period. Thereby, such initiatives have contributed to the growth of the market for veterinary artificial insemination.

The artificial insemination technique has been commercially available for over 60 years and has been utilized very effectively in the cattle and dairy industry. Various factors such as the risks involved with animal breeding and disease transmission are the major factors leading to market growth. Increasing productivity using AI technology is boosting the market for veterinary artificial insemination. Female offspring born through artificial insemination are found to produce more milk than normal offspring. The use of semen extenders containing antibiotics is also helpful in preventing the transmission of bacterial diseases. Furthermore, the entire procedure of AI is considered to be much more hygienic than natural mating.

Moreover, as the production conditions and the farmers' needs evolve, many of the animal breeds are no longer suitable for the majority of farms. However, artificial insemination is used as a preferred reproduction method for such breeds and makes it possible to continue to farm the breeds in situ. Associated advantages such as increased efficiency of bull usage, genetic selection, decreased cost of housing, handling bull, and safety for farmers and animals are further anticipated to increase adoption of AI in the coming years. Increasing calf prices is also major factor for adopting the AI technique. According to a report published by the Beef Cattle Research Council in March 2018, bull prices were USD 5,500 to USD 8,000 in Canada from 2015 to 2016. These prices decreased from USD 4,500 to USD 6,500 from 2017 to 2018 owing to the adoption of AI.

The demand for the genetically superior breed of animals is increasing, which in turn is increasing the demand for artificial insemination procedures in animals. The industry players are continuously trying to develop new products along with partnerships, collaboration, and acquisitions to sustain their market share. For instance, in August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the U.K. In May 2018, Recombinetics partnered with SEMEX for the implementation of a precision breeding program that improved animal health and well-being through hornless dairy cattle genetics.

Animal Type Insights

Based on animal type, the cattle segment dominated the market for veterinary artificial insemination and accounted for the largest revenue share of over 36.0% in 2021. The swine segment on the other hand is projected to grow at the fastest rate of over 6.0% over the forecast period. This is owing to increasing advancements in bovine and swine genetics, widespread adoption of AI in cattle and pig breeding across key markets, and the need to produce sustainable animals. DanBred, based in Denmark for example, helps offer superior bovine genetics through DanBred AI. The semen and the genetic progress of the herd can be tracked with GenePro for better accountability and ROI.

Advancements in bovine genetics can be evaluated with the genetic base change numbers that quantify the actual progress made for each trait within a breed. The base change represents the adjusted Predicted Transmitting Abilities (PTAs) for each trait and for every animal in a breed. The number is reset to 0 every 5 years. Alta Genetics Inc. for instance, reported notable progress for the production traits in both Jerseys and Holsteins from 2015 to 2020. The company’s Holstein and Jersey breeds were rated favorably for production traits such as milk, fat, protein, Daughter Pregnancy Rate (DPR), and more.

Product Insights

The normal semen segment dominated the market for veterinary artificial insemination and accounted for the revenue share of 79.5% in 2021. The market is expected to maintain its position during the forecast period. The high segmental revenue is attributed to the low price of normal semen as compared to sexed semen and high fertility rates. For instance, according to a study published by the Italian Journal of Animal Science in May 2017, the conception rate of sexed semen as a percentage of normal semen ranged from 71.8% to 78.5%, which was indicative that normal semen had a higher fertility rate than sexed semen.

The sexed semen segment is expected to show the fastest growth in the market for veterinary artificial insemination over the forecast period. This is due to increasing adoption to promote the rate of herd expansion and supportive government policies. In June 2021, the Indian government subsidized the price of sexed semen straws. This partnership between the government and Genus ABS would help dairy farmers in the Indian state of Maharashtra by bringing down the price of sex-sorted semen from USD 17.50 to USD 1. The Agriculture and Horticulture Development Board in the U.K. too reported a surge in sexed semen sales in 2020 owing to improvements in success rates and competitive pricing.

End-user Insights

The animal husbandry segment dominated the market for veterinary artificial insemination and accounted for the largest revenue share of around 78.1% in 2021. The growth can be attributed to the majority of the semen collection and AI procedures being performed on-site in breeding farms. Moreover, increasing government initiatives, technological advancements, and demand for milk and protein are further increasing the adoption of AI technology. For instance, in June 2020 Indian government approved around USD 2.06 billion for Animal Husbandry Infrastructure Development Fund (AHIDF). In February 2018, Alibaba Cloud, DEKON Group, and Sichuan Tequ Group collaborated to use ET Brain technology for pig breeding in China.

Global veterinary artificial insemination market share, by end-user, 2021 (%)

The others segment comprising of veterinary hospitals and clinics is anticipated to grow at the fastest rate in the market for veterinary artificial insemination in the coming years. An increasing number of hospitals carrying out artificial insemination procedures in developed and developing countries, supportive initiatives, and the rising number of veterinarians are factors driving the market. For instance, as per the AI Development Plan launched in 2017 in China, the Chinese government describes artificial insemination as a new focal point of international competition and declared itself open to the world’s premier AI innovation center by 2030.

Regional Insights

North America dominated the veterinary artificial insemination market and accounted for the largest revenue share of over 29.0% in 2021. This is owing to well-equipped animal husbandry industry, growing awareness and adoption of AI for breeding livestock, and presence of key companies such as STgenetics.STgenetics for instance is a leading player in the sexed semen market. The Sex Sorted Semen produced by the company offers an average of 93.0% female purity for various breeds of cattle and buffaloes.

In Asia Pacific, the market for veterinary artificial insemination is estimated to witness the fastest CAGR of over 7.0% during the forecast period. Large cattle inventory, a thriving dairy industry, supportive government initiatives, and growing awareness about the benefits of artificially inseminating livestock are propelling market growth. For instance, in August 2019 Department of Veterinary, Gynaecology, and Obstetrics of Madras Veterinary College started artificial insemination in cattle using sexed semen. In 2020, the government allowed Milk Producer Companies to establish multipurpose AI technicians in rural areas following necessary approval to boost AI coverage in the country. Many milk-producing companies in India have also initiated doorstep AI delivery to support market growth.

Key Companies & Market Share Insights

The market for veterinary artificial insemination is competitive in nature. Market players implement strategic initiatives, such as R&D, product development and launches, expansion of distribution network, and global footprint. In addition, owing to growing mergers and acquisitions, and establishment of co-operatives, the market is undergoing consolidation. The continuous demand from the food industry is further propelling the market growth for genetically superior animals to increase productivity. The product portfolio thus keeps undergoing expansion and enhancements to include frozen semen, fresh semen, sexed semen, high genetic merit semen, and others.

New disease-resistant breed development helps companies to expand their existing portfolio and customer base. For instance, in May 2019 Genus plc partnered with Beijing Capital Agribusiness (BCA) located in China. BCA is expected to assist the company in patented technology applications to develop Porcine Reproductive and Respiratory Syndrome Virus (PrRVS)-resistant animal. In April 2018, Select Sires introduced an Elite sexed fertility product line. The company would identify sires with superior fertility sex-sorted semen using an Elite Sexed Fertility designation, enhancing its product base. Some of the prominent players in the veterinary artificial insemination market include:  

  • Genus

  • URUS Group LP

  • CRV


  • Viking Genetics

  • Select Sires Inc.

  • Swine Genetics International

  • Shipley Swine Genetics

  • Stallion AI Services Ltd

  • STgenetics

Veterinary Artificial Insemination Market Report Scope

Report Attribute


Market size value in 2022

USD 4.4 billion

Revenue forecast in 2030

USD 7.4 billion

Growth Rate

CAGR of 6.5% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Animal type, product, end-user, region

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Netherlands; Denmark; Russia; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Israel

Key companies profiled

Genus; URUS Group LP; CRV; SEMEX; Viking Genetics; Select Sires Inc.; Swine Genetics International; Shipley Swine Genetics; Stallion AI Services Ltd; STgenetics

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this report, Grand View Research has segmented the global veterinary artificial insemination market report on the basis of animal type, product, end user, and region:

  • Animal Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Cattle

    • Swine

    • Ovine & Caprine

    • Equine

    • Others

  • Product Outlook (Revenue, USD Million, 2017 - 2030)

    • Normal Semen

    • Sexed Semen

  • End-user Outlook (Revenue, USD Million, 2017 - 2030)

    • Animal Husbandry

    • Others

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Netherlands

      • Denmark

      • Russia

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • Israel

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon